Skip to content

Live Events

Live Events

Live Events

Live Events

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 201 - 225 of 2,995

«
1
…
7
8
9
10
11
…
120
»

Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates

Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates

By: Hope Rugo, MD, FASCO

Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates

Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates

By: Hope Rugo, MD, FASCO

The Entire Sepctrum of Her-2 Management in Breast Cancer Disease: All Clinical Settings

The Entire Sepctrum of Her-2 Management in Breast Cancer Disease: All Clinical Settings

By: Hope S Rugo - MD

Updates in the Management of HER-2 Positive Breast Cancer

Updates in the Management of HER-2 Positive Breast Cancer

By: Hope S Rugo, MD

Updates in the Management of HER2 Positive Breast Cancer

Updates in the Management of HER2 Positive Breast Cancer

By: Hope S. Rugo, MD

The Entire Sepctrum of Her-2Management in Breast Cancer Disease - All Clinical Settings

The Entire Sepctrum of Her-2Management in Breast Cancer Disease - All Clinical Settings

By: Hope S. Rugo, MD

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

By: Hope S. Rugo, MD

Triple Negative Breast Cancer: Optimal Neoadjuvant Therapy and New Directions

Triple Negative Breast Cancer: Optimal Neoadjuvant Therapy and New Directions

By: Hope S. Rugo, MD

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

By: Hope S. Rugo, MD

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Antibody Drug Conjugates: New Agents and Optimal Sequencing

By: Hope S. Rugo, MD, FASCO

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Antibody Drug Conjugates: New Agents and Optimal Sequencing

By: Hope S. Rugo, MD, FASCO

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid A. Mayer, MD, MSCI

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid A. Mayer, MD, MSCI

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid Mayer, MD

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

By: Ingrid Mayer, MD

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

By: Jane Lowe Meisel, MD

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

By: Jane Lowe Meisel, MD

ADC in Breast Cancer Management

ADC in Breast Cancer Management

By: Jane Lowe Meisel, MD

ADC in Breast Cancer Management

ADC in Breast Cancer Management

By: Jane Lowe Meisel, MD

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

By: Jane Meisel, MD

Advances in HER2 Positive Metastatic Breast Cancer

Advances in HER2 Positive Metastatic Breast Cancer

By: Janice Lu, MD, PhD

Radiation Theraphy and Genomic Interactions in Breast Cancer Patients

Radiation Theraphy and Genomic Interactions in Breast Cancer Patients

By: Javier F. Torres-Roca, MD

Triple Negative Breast Cancer

Triple Negative Breast Cancer

By: Jennifer R. Diamond, MD

Triple Negative Breast Cancer

Triple Negative Breast Cancer

By: Jennifer R. Diamond, MD

Advanced Breast Cancer: State of the Art

Advanced Breast Cancer: State of the Art

By: Joanne Mortimer, MD, FACP, FASCO

«
1
…
7
8
9
10
11
…
120
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok